ConvaTec Group PLC (CNVVY)
OTCMKTS · Delayed Price · Currency is USD
12.49
+0.22 (1.79%)
Aug 7, 2025, 3:57 PM EDT
ConvaTec Group Market Cap
ConvaTec Group has a market cap or net worth of $6.33 billion as of August 8, 2025. Its market cap has decreased by -2.11% in one year.
Market Cap
6.33B
Enterprise Value
7.55B
Revenue
2.36B
Ranking
n/a
PE Ratio
29.21
Stock Price
$12.49
Market Cap Chart
Since October 26, 2016, ConvaTec Group's market cap has increased from 5.37B to 6.33B, an increase of 17.81%. That is a compound annual growth rate of 1.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 6, 2025 | 6.15B | 8.62% |
| Dec 31, 2024 | 5.67B | -10.67% |
| Dec 29, 2023 | 6.34B | 10.75% |
| Dec 30, 2022 | 5.73B | 8.81% |
| Dec 31, 2021 | 5.26B | -3.23% |
| Dec 31, 2020 | 5.44B | 4.44% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Oct 26, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 823.67M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 532.81M |
| Glass House Brands | 467.07M |
| Northwest Biotherapeutics | 366.31M |
| CytoDyn | 347.26M |
| American Oncology Network | 330.70M |